Erector Spinae Plane Block Versus Oblique Subcostal Transverses Abdominis Plane Block

July 11, 2023 updated by: Michael Adel Shaker, Zagazig University

Erector Spinae Plane Block Versus Oblique Subcostal Transverses Abdominis Plane Block for Controlling Postoperative Pain After Umbilical Hernia Repair

Comparing the impact of bilateral erector spinae plane block and transverse abdominis plane block on improving quality of pain management after umbilical hernia repair.

Study Overview

Detailed Description

Postoperative pain is an important problem after umbilical hernia repair which has negative effects on patient's hemodynamics and cause delayed ambulation resulting in prolonged duration of hospital stay and poor patient satisfaction.

Multiple analgesic strategies have been proposed including Non steroidal anti-inflammatory drugs (NSAIDs), opioids, epidural analgesia. Each of them has its limitations.

Ultra¬sound guided regional anesthesia techniques for abdominal wall can be effective components of multimodal postoperative analgesia with limited side-effects Erector spinae plane (ESP) block is a promising para-spinal bock that can achieve both visceral and somatic abdominal analgesia if the injection was performed at a lower thoracic level. Transverse abdominis plane (TAP) block which is considered a peripheral nerve block that is aimed at anesthetizing nerves supplying the anterior abdominal wall.

We will compare between erector spinae plane block and transverse abdominis plane block for controlling postoperative pain after umbilical hernia repair.

Patients will be allocated randomly into two equal groups by a computer-generated randomization table Group (E) (n=26): Patients will receive erector spinae plane (ESP) block after completion of surgery.

Group (T) (n= 26): Patients will receive oblique subcostal transverse abdominis plane (TAP) block after completion of surgery

Study Type

Interventional

Enrollment (Estimated)

52

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

  • Name: salwa s ElSherbeny, lecturer
  • Phone Number: 002 01128595629

Study Locations

    • Sharkia
      • Zagazig, Sharkia, Egypt, 44511
        • Recruiting
        • Zagazig university hospital
        • Contact:
          • Hala A ALsadek, professor
          • Phone Number: 002 01224897773

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

21 years to 60 years (Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Patients scheduled for elective umbilical hernia repair.
  • Patient acceptance.
  • Both sex
  • Patient's age 21 - 60 years.
  • Patients with American Society of Anesthesiologists (ASA) physical status I, II.
  • BMI 25 - 30 kg m-2.

Exclusion Criteria:

  • Uncooperative patients and patients with psychological problems.
  • Patients with liver or renal impairment.
  • Patients with contraindication to regional anesthesia.
  • Patients with history of allergy to drug used in the study.
  • Patients with chronic pain.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: erector spinae plane (ESP) block group ( (E) group)
Under aseptic conditions, a high frequency linear transducer will be placed on the spinous process at T8 level on the parasagittal plane and then slid 2.5-3 cm laterally to visualize the transverse process and erector spinae muscle.
Using the in plane technique, the needle will be advanced between the transverse process and erector spinae muscle. The correct location will be confirmed using 1ml of Local Anesthetic (LA) to view hydrodissection(12). 19ml of LA will be injected between the muscle and transverse process.
Active Comparator: oblique subcostal transverse abdominis plane (TAP) block ( (T) group) )
Under aseptic conditions, the probe will be initially placed below the xyphoid process to view the linea alba, then directed obliquely down the costal margin while keeping the rectus abdominis muscle in view. The transverse abdominis muscle come into view below the rectus abdominis muscle. The probe will be advanced further until the semilunaris is viewed.
An echogenic needle will be inserted in-plane until the needle tip reaches the fascia between the rectus abdominis and the transverse abdominis muscles. Once the needle enters the TAP plane, a dynamic injection can be performed by advancing the needle under ultrasound guidance laterally in the pocket created by the initial injection of 5 - 10 mL of local anesthetic; as the needle is advanced, the remaining local anesthetic will be injected. This allows for a more lateral spread of the local anesthetic

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Postoperative analgesic requirements
Time Frame: 24 hours postoperative
measuring the total doses of analgesic required to relieve the pain
24 hours postoperative

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Postoperative pain severity using Visual Analogue scale
Time Frame: 24 hours postoperative
assessing pain severity using Visual Analogue scale (VAS) (0-100mm)
24 hours postoperative
Postoperative pain severity using Verbal Rating Scale
Time Frame: 24 hours postoperative
assessing pain severity using Verbal Rating Scale (mild, moderate and severe)
24 hours postoperative
Postoperative pain severity using Numeric Rating Scale
Time Frame: 24 hours postoperative
assessing pain severity using Numeric Rating Scale (NRS) (0-10; 0, no pain; 10, worst pain)
24 hours postoperative
Postoperative heart rate changes
Time Frame: 24 hours postoperative
monitoring postoperative changes in the heart rate (HR) measured by beat per minute (BPM) and comparing it with the preoperative measures
24 hours postoperative
Postoperative blood pressure changes
Time Frame: 24 hours postoperative
monitoring postoperative changes in the blood pressure (BP) measured by mm Hg and comparing it with the preoperative measures.
24 hours postoperative
Incidence of postoperative side effects
Time Frame: 24 hours postoperative
recording any postoperative complications as nausea and vomiting
24 hours postoperative
Duration of postoperative hospital stay
Time Frame: 24 hours postoperative
measuring the delay in discharging the patients postoperative because of the pain
24 hours postoperative

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: MICHAEL A shaker, lecturer, Zagazig University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 15, 2021

Primary Completion (Estimated)

November 15, 2023

Study Completion (Estimated)

December 15, 2023

Study Registration Dates

First Submitted

December 22, 2021

First Submitted That Met QC Criteria

March 17, 2022

First Posted (Actual)

March 18, 2022

Study Record Updates

Last Update Posted (Actual)

July 12, 2023

Last Update Submitted That Met QC Criteria

July 11, 2023

Last Verified

July 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 8034-7-11-2021

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Postoperative Pain

Clinical Trials on erector spinae plane (ESP) block

Subscribe